ERs to test new tool that helps patients prevent HIV with PrEP

NCT ID NCT07279129

First seen Jan 05, 2026 · Last updated May 23, 2026 · Updated 27 times

Summary

This study aims to see if a personalized decision support tool can help people in emergency rooms and urgent care clinics start and continue taking PrEP, a daily pill that prevents HIV. The tool will address each person's medical and social needs to build confidence in using PrEP. The study will involve 120 HIV-negative adults in Baltimore and Washington, DC, and will track how many fill their prescription, attend follow-up appointments, and keep taking PrEP over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • George Washington University Emergency Department

    Washington D.C., District of Columbia, 20037, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Johns Hopkins Hospital Emergency Department

    Baltimore, Maryland, 21287, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.